To join a lung cancer clinical trial in United States, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in United States directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.

What phases are lung cancer trials in United States?

Active lung cancer trials in United States span Phase 2, Phase 1, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.

Browse More

All United States Trials → Global lung cancer Trials → All Countries → All Trials →

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology

Active Trials in United States (22)

Support for Cancer Patients Awaiting News

Stereotactic Magnetic Resonance Guided Radiation Therapy

Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

CHAMP Lung Cancer Screening Program

Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

Accelerated Pulmonary Rehabilitation in the Preoperative Period

Prediction Augmented Screening Initiative

Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer

Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

Next Generation Chest X-Ray Tomosynthesis for Screening of Lung Cancer

Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens

The Florida ASCENT Study

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

A Community Health Intervention to Improve Lung Cancer Screening Uptake in Community Health Centers

DNA Analysis of Blood and Tissue From Patients With Lung Cancer

Axelopran for Advanced Cancer in Patients Receiving Opioids

SPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based Classifier

Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT

Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients

Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES

Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements

Frequently Asked Questions